Zydus Secures Rights to Market MonoFerric Injections in India and Nepal
On Friday, Zydus Life sciences Ltd announced that it had acquired rights to market MonoFerric (iron isomaltose) injection, used to treat iron deficiency among adult...
Tag : Zydus Cadila
First Batch of ZyCoV-D Supplied to Govt
Zydus Cadila announced in a regulatory filing that it supplied the first batch of its Covid-19 vaccine, ZyCoV-D, to the Central Government. In November 2021,...
India Soon Launch World’s First DNA Vaccine for Covid
Prime Minister Narendra Modi, during his Saturday’s address to the nation, had said that the world’s first DNA vaccine against the Covid-19 will soon be...
Zydus Cadila’s 3-Dose Vaccine to Cost Rs 1,128
Zydus Cadila’s 3-dose needle-free coronavirus vaccine will cost Rs 1,128 to the government. “Zydus Cadila has got an order to supply 1 crore doses of...
ZyCoV-D to Get Permission For Emergency Use This Week
Zydus Cadila‘s Covid-19 vaccine ZyCoV-D is getting a nod for emergency use in India by this week. Union Health Minister Mansukh Mandaviya in the Rajya...
Zydus Cadila Covid-19 Vaccine To Approve This Week
A decision on the approval of Zydus Cadila‘s Covid-19 vaccine is likely this week. “The vaccine has been tested on adults as well as children...
Zydus Cadila Applies for Emergency Use of Covid-19 Vaccine
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
Zydus Cadila Gets USFDA Tentative Nod for Epilepsy Treatment Drug
On Monday, Zydus Cadila said that they received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets. Zydus Cadila has...
Zydus Gets SEC Nod For Trials of Covid-19 Antibody
Pharmaceuticals major Zydus Cadila has received permission from the Subject Expert Committee (SEC) to conduct clinical trials of its monoclonal antibodies (mAbs) based cocktail for...
Zydus Cadila Launches Breast Cancer Treatment Drug Ujvira
Zydus Cadila has launched Ujvira and has used drugs for the treatment of breast cancer. The company has launched Trastuzumab Emtansine, the first antibody-drug conjugate...